Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia - No Study Results Posted

Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia (SPECTRUM)

This study has been completed.

Study NCT00640601 Information provided by AstraZeneca

First Received: March 17, 2008 Last Updated: August 5, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2010
Primary Completion Date:	July 2010 (Final data collection date for primary outcome measure)